What to expect when you take Orphenadrine citrate and Keppra?

Do you take Orphenadrine citrate and Keppra? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 10, 2019

7,107 reports have been studied.


Females aged 50 to 59 :

4,094 related reports were analyzed:

Most common symptoms:

Anaemia
  • 5.68% for females aged 50 (±5) who take Orphenadrine citrate
Back pain
  • 10.51% for females aged 50 (±5) who take Orphenadrine citrate
Chest pain
  • 7.95% for females aged 50 (±5) who take Orphenadrine citrate
Convulsion
  • 11.84% for females aged 50 (±5) who take Keppra
Cough
  • 5.97% for females aged 50 (±5) who take Orphenadrine citrate
Depression
  • 6.82% for females aged 50 (±5) who take Orphenadrine citrate
Dizziness
  • 6.82% for females aged 50 (±5) who take Orphenadrine citrate
  • 6.57% for females aged 50 (±5) who take Keppra
Drug ineffective
  • 5.11% for females aged 50 (±5) who take Orphenadrine citrate
Dyspnea
  • 11.36% for females aged 50 (±5) who take Orphenadrine citrate
Fall
  • 8.81% for females aged 50 (±5) who take Orphenadrine citrate
Fatigue
  • 6.31% for females aged 50 (±5) who take Keppra
  • 5.11% for females aged 50 (±5) who take Orphenadrine citrate
Fever
  • 7.95% for females aged 50 (±5) who take Orphenadrine citrate
Headache
  • 11.93% for females aged 50 (±5) who take Orphenadrine citrate
  • 5.64% for females aged 50 (±5) who take Keppra
High blood pressure
  • 9.66% for females aged 50 (±5) who take Orphenadrine citrate
Hypoaesthesia
  • 6.53% for females aged 50 (±5) who take Orphenadrine citrate
Hypotension
  • 5.11% for females aged 50 (±5) who take Orphenadrine citrate
Insomnia
  • 6.82% for females aged 50 (±5) who take Orphenadrine citrate
Intervertebral disc degeneration
  • 5.97% for females aged 50 (±5) who take Orphenadrine citrate
Joint pain
  • 10.8% for females aged 50 (±5) who take Orphenadrine citrate
Nausea
  • 8.81% for females aged 50 (±5) who take Orphenadrine citrate
  • 5.32% for females aged 50 (±5) who take Keppra
Pain
  • 15.91% for females aged 50 (±5) who take Orphenadrine citrate
Pain in extremity
  • 8.81% for females aged 50 (±5) who take Orphenadrine citrate
Paraesthesia
  • 6.82% for females aged 50 (±5) who take Orphenadrine citrate
Rashes
  • 5.97% for females aged 50 (±5) who take Orphenadrine citrate
Sleep apnea syndrome
  • 6.25% for females aged 50 (±5) who take Orphenadrine citrate
Stress and anxiety
  • 10.23% for females aged 50 (±5) who take Orphenadrine citrate
Tremor
  • 7.95% for females aged 50 (±5) who take Orphenadrine citrate
Weakness
  • 11.08% for females aged 50 (±5) who take Orphenadrine citrate
  • 6.12% for females aged 50 (±5) who take Keppra
Weight decreased
  • 5.4% for females aged 50 (±5) who take Orphenadrine citrate

Most common co-existing conditions:

Convulsion
  • 10.98% for females aged 50 (±5) who take Keppra
Depression
  • 6.82% for females aged 50 (±5) who take Orphenadrine citrate
  • 5.05% for females aged 50 (±5) who take Keppra
Fibromyalgia
  • 5.97% for females aged 50 (±5) who take Orphenadrine citrate
High blood pressure
  • 7.1% for females aged 50 (±5) who take Orphenadrine citrate
  • 5.32% for females aged 50 (±5) who take Keppra
Migraine
  • 5.11% for females aged 50 (±5) who take Orphenadrine citrate
Multiple sclerosis
  • 8.12% for females aged 50 (±5) who take Keppra
Pain
  • 15.63% for females aged 50 (±5) who take Orphenadrine citrate
Rheumatoid arthritis
  • 9.66% for females aged 50 (±5) who take Orphenadrine citrate
Stress and anxiety
  • 5.11% for females aged 50 (±5) who take Orphenadrine citrate
back to top

Males aged 50 to 59 :

3,013 related reports were analyzed:

Most common symptoms:

Back pain
  • 8.41% for males aged 50 (±5) who take Orphenadrine citrate
Chest pain
  • 6.54% for males aged 50 (±5) who take Orphenadrine citrate
Chills
  • 6.54% for males aged 50 (±5) who take Orphenadrine citrate
Convulsion
  • 9.57% for males aged 50 (±5) who take Keppra
Depression
  • 9.35% for males aged 50 (±5) who take Orphenadrine citrate
Dizziness
  • 7.48% for males aged 50 (±5) who take Orphenadrine citrate
Drug ineffective
  • 7.48% for males aged 50 (±5) who take Orphenadrine citrate
Dyspnea
  • 6.54% for males aged 50 (±5) who take Orphenadrine citrate
Fainting
  • 5.61% for males aged 50 (±5) who take Orphenadrine citrate
Fever
  • 7.48% for males aged 50 (±5) who take Orphenadrine citrate
Headache
  • 6.54% for males aged 50 (±5) who take Orphenadrine citrate
Heart attack
  • 5.61% for males aged 50 (±5) who take Orphenadrine citrate
Hyperhidrosis
  • 5.61% for males aged 50 (±5) who take Orphenadrine citrate
Injury
  • 5.61% for males aged 50 (±5) who take Orphenadrine citrate
Insomnia
  • 6.54% for males aged 50 (±5) who take Orphenadrine citrate
Nausea
  • 12.15% for males aged 50 (±5) who take Orphenadrine citrate
Nausea and vomiting
  • 11.21% for males aged 50 (±5) who take Orphenadrine citrate
Pain
  • 8.41% for males aged 50 (±5) who take Orphenadrine citrate
Rashes
  • 7.48% for males aged 50 (±5) who take Orphenadrine citrate
Stress and anxiety
  • 9.35% for males aged 50 (±5) who take Orphenadrine citrate
Tremor
  • 7.48% for males aged 50 (±5) who take Orphenadrine citrate
Weakness
  • 10.28% for males aged 50 (±5) who take Orphenadrine citrate

Most common co-existing conditions:

Convulsion
  • 9.46% for males aged 50 (±5) who take Keppra
Depression
  • 6.54% for males aged 50 (±5) who take Orphenadrine citrate
High blood pressure
  • 5.61% for males aged 50 (±5) who take Keppra
  • 5.61% for males aged 50 (±5) who take Orphenadrine citrate
Pain
  • 14.95% for males aged 50 (±5) who take Orphenadrine citrate
Rheumatoid arthritis
  • 7.48% for males aged 50 (±5) who take Orphenadrine citrate
back to top

Do you take Orphenadrine citrate and Keppra:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Orphenadrine citrate

Orphenadrine citrate has active ingredients of orphenadrine citrate. It is often used in muscle aches. (latest outcomes from Orphenadrine citrate 702 users)

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 46,892 users)

General study

Related publications that referenced our studies


Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!